Paper Details

  1. Home
  2. Paper Details

Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence.

Author: BentAlfred E, BumpRichard C, GousseAngelo E, HendrixSusan L, KlutkeCarl G, MongaAsh K, MuramDavid, YalcinIlker, YuenChui K

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Duloxetine demonstrated significant efficacy in women with mixed urinary incontinence. The median percentage reduction in incontinence episode frequency was 60% with duloxetine compared to 47% with placebo.
Paper Details　
Original Abstract of the Article :
AIMS: Evaluate duloxetine in the treatment of women with mixed urinary incontinence (MUI). MATERIALS AND METHODS: 588 women, 19-85 years old with >or=4 incontinence episodes/week were randomly assigned to duloxetine 80 mg/day (N = 300) or placebo (N = 288). Patients were classified into three sympt...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/nau.20471

データ提供：米国国立医学図書館（NLM）

Treating Mixed Urinary Incontinence: The Role of Duloxetine

This study explores the potential of [duloxetine] for treating [mixed urinary incontinence (MUI)]. Imagine a desert where the researchers are seeking a solution to a common problem – [urinary incontinence]. They conducted a study to evaluate the effectiveness of [duloxetine] in reducing [urinary incontinence] symptoms. Their findings provide valuable insights into the potential role of [duloxetine] in managing this condition.

Duloxetine: A Promising Treatment for Mixed Urinary Incontinence

The researchers found that [duloxetine] significantly reduced [urinary incontinence] episodes in women with [mixed urinary incontinence (MUI)]. This suggests that [duloxetine] could be a valuable addition to the treatment options for managing this condition. However, it is crucial to note that individual responses to [duloxetine] may vary.

Understanding Urinary Incontinence: Seeking Medical Guidance

If you experience [urinary incontinence], it's essential to consult with a medical professional to determine the underlying cause and explore appropriate treatment options. This research, like a camel finding a hidden oasis in the desert, offers a potential solution for managing this common concern.

Dr. Camel's Conclusion

This research provides valuable insights into the potential of [duloxetine] for treating [mixed urinary incontinence (MUI)]. The findings suggest that [duloxetine] could offer relief from [urinary incontinence] symptoms for many women. This research reminds us that even in the vast and complex desert of medical challenges, we can find solutions to improve the lives of those seeking relief from [urinary incontinence]. It's a testament to the power of scientific research to unlock new pathways to better health.

Date :
  1. Date Completed 2008-05-02
  2. Date Revised 2016-11-24
Further Info :

Pubmed ID

17580357

DOI: Digital Object Identifier

10.1002/nau.20471

Related Literature

Article Analysis
・Effective treatment of urinary incontinence
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.